AccuVein Inc.

Key People

• Daniel Delaney - Chief Operating Officer

Assessment

Team

Aspect: Multiple successful MedTech entrepreneurs
Summary: The leadership team comprises experienced professionals with a strong background in medical technology.

AccuVein's leadership includes individuals with significant experience in the MedTech industry, contributing to the company's innovative product development and market success.

Clinical Need

Aspect: Very Strong
Summary: AccuVein addresses a critical need in healthcare by improving vein visualization, reducing patient discomfort and procedure time.

The AV400 device significantly aids healthcare professionals in locating veins, particularly in challenging cases, thereby improving patient outcomes and reducing complications.

Competition

Aspect: Somewhat crowded
Summary: The vein visualization market includes several competitors, but AccuVein maintains a leading position.

AccuVein holds a significant market share, with competitors like Christie Medical Holdings and TransLite LLC also present. Continuous innovation is essential to maintain leadership.

Technical Challenge

Aspect: Predictable
Summary: The technology behind vein visualization is well-established, with manageable technical challenges.

Near-infrared vein visualization is a mature technology, enabling AccuVein to focus on enhancing device features and user experience.

Patent

Aspect: Very Strong
Summary: AccuVein has secured over 50 patents, reflecting a robust intellectual property portfolio.

The company's numerous patents cover various aspects of vein visualization technology, ensuring protection against competitors and fostering continued innovation.

Financing

Aspect: Well-funded
Summary: AccuVein has secured substantial funding, including a $22.5 million Series B round.

The Series B financing led by MVM Life Science Partners and Bessemer Venture Partners has enabled AccuVein to invest in product development and expand its market presence.

Regulatory

Aspect: 510k/PMA
Summary: AccuVein's products have obtained necessary regulatory approvals, facilitating market entry.

The AV400 device has received FDA 510(k) clearance and CE certification, allowing for distribution in key markets and demonstrating adherence to safety and efficacy standards.

Opportunity Rollup

Odds of Success

3.8

Peak Market Share

4.85

Segment CAGR

6.74%

Market Segment

Medical Imaging Devices

Market Sub Segment

Vein Visualization Devices

Key Takeaway

AccuVein's strong market position, innovative technology, and robust patent portfolio position it well to capitalize on the growing demand for vein visualization devices, despite facing competitive and regulatory challenges.